SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 29th, 2020 • Achieve Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJune 29th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 29, 2020 between Achieve Life Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).